BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23394467)

  • 1. Comparative performances of prognostic indexes for breast cancer patients presenting with brain metastases.
    Braccini AL; Azria D; Thezenas S; Romieu G; Ferreri JM; Jacot W
    BMC Cancer; 2013 Feb; 13():70. PubMed ID: 23394467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of nine prognostic scores in patients with brain metastases of breast cancer receiving radiotherapy of the brain.
    Laakmann E; Riecke K; Goy Y; Kersten JF; Krüll A; Müller V; Petersen C; Witzel I
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):325-32. PubMed ID: 26424693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the new Graded Prognostic Assessment scale for brain metastases: a multicenter prospective study.
    Villà S; Weber DC; Moretones C; Mañes A; Combescure C; Jové J; Puyalto P; Cuadras P; Bruna J; Verger E; Balañà C; Graus F
    Radiat Oncol; 2011 Mar; 6():23. PubMed ID: 21366924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer patients with brain metastases or leptomeningeal disease: 10-year results of a national cohort with validation of prognostic indexes.
    Znidaric T; Gugic J; Marinko T; Gojkovic Horvat A; Paulin Kosir MS; Golo D; Ivanetic Pantar M; Ratosa I
    Breast J; 2019 Nov; 25(6):1117-1125. PubMed ID: 31286623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience.
    Griguolo G; Jacot W; Kantelhardt E; Dieci MV; Bourgier C; Thomssen C; Bailleux C; Miglietta F; Braccini AL; Conte P; Ferrero JM; Guarneri V; Darlix A
    Breast; 2018 Feb; 37():36-41. PubMed ID: 29073498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.
    Viani GA; Castilho MS; Salvajoli JV; Pellizzon AC; Novaes PE; Guimarães FS; Conte MA; Fogaroli RC
    BMC Cancer; 2007 Mar; 7():53. PubMed ID: 17386108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic treatment after whole-brain radiotherapy may improve survival in RPA class II/III breast cancer patients with brain metastasis.
    Zhang Q; Chen J; Yu X; Ma J; Cai G; Yang Z; Cao L; Chen X; Guo X; Chen J
    J Neurooncol; 2013 Sep; 114(2):181-9. PubMed ID: 23743596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival outcomes of breast cancer patients with brain metastases: A multicenter retrospective study in Korea (KROG 16-12).
    Kim JS; Kim K; Jung W; Shin KH; Im SA; Kim HJ; Kim YB; Chang JS; Choi DH; Park YH; Kim DY; Kim TH; Choi BO; Lee SW; Kim S; Kwon J; Kang KM; Chung WK; Kim KS; Nam JH; Yoon WS; Kim JH; Cha J; Oh YK; Kim IA
    Breast; 2020 Feb; 49():41-47. PubMed ID: 31677532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival time following resection of intracranial metastases from NSCLC-development and validation of a novel nomogram.
    Ji X; Zhuang Y; Yin X; Zhan Q; Zhou X; Liang X
    BMC Cancer; 2017 Nov; 17(1):774. PubMed ID: 29157203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Institutional, retrospective analysis of 777 patients with brain metastases: treatment outcomes and diagnosis-specific prognostic factors.
    Antoni D; Clavier JB; Pop M; Schumacher C; Lefebvre F; Noël G
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):630-7. PubMed ID: 23582409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: extra-cranial disease progression is an independent risk factor.
    Zhuang Q; Wong RX; Lian WX; Li YQ; Wong FY
    Ann Palliat Med; 2019 Sep; 8(4):390-400. PubMed ID: 30943738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Survival of Patients with Brain Metastases According to Prognostic Indexes and Treatment Strategies.
    Saginc H; Baltalarli PB; Sagtas E; Coskun ME
    Turk Neurosurg; 2020; 30(6):822-831. PubMed ID: 32091122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases.
    Sperduto PW; Kased N; Roberge D; Xu Z; Shanley R; Luo X; Sneed PK; Chao ST; Weil RJ; Suh J; Bhatt A; Jensen AW; Brown PD; Shih HA; Kirkpatrick J; Gaspar LE; Fiveash JB; Chiang V; Knisely JP; Sperduto CM; Lin N; Mehta M
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2111-7. PubMed ID: 21497451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain Metastases.
    Subbiah IM; Lei X; Weinberg JS; Sulman EP; Chavez-MacGregor M; Tripathy D; Gupta R; Varma A; Chouhan J; Guevarra RP; Valero V; Gilbert MR; Gonzalez-Angulo AM
    J Clin Oncol; 2015 Jul; 33(20):2239-45. PubMed ID: 25987700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain metastases from breast carcinoma: validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score.
    Le Scodan R; Massard C; Mouret-Fourme E; Guinebretierre JM; Cohen-Solal C; De Lalande B; Moisson P; Breton-Callu C; Gardner M; Goupil A; Renody N; Floiras JL; Labib A
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):839-45. PubMed ID: 17544592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of Recursive Partitioning Analysis and Diagnosis-Specific Graded Prognostic Assessment in patients treated initially with radiosurgery alone.
    Likhacheva A; Pinnix CC; Parikh N; Allen PK; Guha-Thakurta N; McAleer M; Sulman EP; Mahajan A; Shiu A; Luo D; Chiu M; Brown PD; Prabhu SS; Chang EL
    J Neurosurg; 2012 Dec; 117 Suppl(0):38-44. PubMed ID: 23205787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
    Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS
    J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of prognostic scores of brain metastases from lung adenocarcinoma with EGFR mutations.
    Li H; Lian J; Jin H; Wang W; Cao J; Zhang X; Song X; Jia S; Jia H; Ren J; Han S; Yang W; Xi Y; Lan S
    J Neurooncol; 2017 May; 133(1):129-135. PubMed ID: 28391386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical utility of prognostic scoring systems in patients with brain metastases treated with radiosurgery.
    Zindler JD; Rodrigues G; Haasbeek CJ; De Haan PF; Meijer OW; Slotman BJ; Lagerwaard FJ
    Radiother Oncol; 2013 Mar; 106(3):370-4. PubMed ID: 23522151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems.
    Lorenzoni J; Devriendt D; Massager N; David P; Ruíz S; Vanderlinden B; Van Houtte P; Brotchi J; Levivier M
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):218-24. PubMed ID: 15337559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.